USFDA grants accelerated approval for Mirati Therapeutics lung cancer drug KRAZATI Ruchika Sharma13 Dec 2022 3:30 PM ISTSan Diego: Mirati Therapeutics, Inc., a targeted oncology company, has announced that the U.S. Food and Drug Administration (USFDA) has granted...
More frequent CT scans not associated with improved outcomes after lung cancer surgery Dr. Kamal Kant Kohli30 Nov 2022 9:30 AM ISTLung cancer is United States' second most prevalent type of cancer and leading cause of cancer deaths. In cases involving early-stage non small cell...
Lung cancer diagnosis at early stage via CT screening increases long-term survival rate Dr. Kamal Kant Kohli29 Nov 2022 9:30 AM ISTUSA: A lung cancer diagnosis at an early stage via low-dose CT screening significantly improves the long-term survival rate of cancer patients,...
Medical Bulletin 22/November/2022 Dr Rashi Prakash22 Nov 2022 2:00 PM ISTHere are the top medical news for the day:Artificial neural networks learn better when they spend time not learning at allArtificial neural networks...
Tumour matrix profiling gives clues to progression of some lung cancers Dr Rashi Prakash22 Nov 2022 9:15 AM ISTSquamous cell carcinoma is the second most prevalent type of lung cancer and treatment options for these patients remain limited and have remained...
Novel PET agent effectively detects multiple cancers, identifies patients for targeted therapies Dr. Kamal Kant Kohli19 Nov 2022 10:00 AM ISTA new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from...
Dual-energy CT can assess physiologic changes after lung cancer surgical resection Dr. Kamal Kant Kohli8 Nov 2022 8:00 PM ISTAccording to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), metrics derived from dual-energy CT (DECT) can provide...
Cardiovascular diseases linked with development and survival in lung cancer Jacinthlyn Sylvia1 Nov 2022 7:30 PM ISTA new study published in Frontiers in Oncology suggests that the increased risk of lung cancer incidence and mortality associated with the diagnosis...
Sugammadex bests Neostigmine in faster recovery of rocuronium induced neuromuscular block Dr.Niharika Harsha B31 Oct 2022 8:00 PM ISTRecent research found that Sugammadex has accelerated the recovery of the rocuronium-induced neuromuscular block when compared with Neostigmine. The...
Statins may reduce risk of lung cancer among patients of idiopathic pulmonary fibrosis Dr. Kamal Kant Kohli31 Oct 2022 12:00 PM ISTKOREA: According to research findings presented at the American College of Chest Physicians (CHEST) 2022 Annual Meeting, conducted on October 16–19 in...
Targeted lung cancer drug repotrectinib shows promise in TRIDENT-1 trial Dr. Kamal Kant Kohli29 Oct 2022 4:45 AM ISTResearchers have found in TRIDENT-1 trial that targeted drug repotrectinib could help treat patients with a certain type of non-small cell lung...
Medical Bulletin 27/October/2022 Isra Zaman27 Oct 2022 1:00 PM ISTHere are the top medical news for the day:Banana protein may have the potential to work against SARS-CoV-2A paper in Cell Reports Medicine details the...
